+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Angioplasty Balloons Market - Global Forecast 2026-2032- Product Image
Angioplasty Balloons Market - Global Forecast 2026-2032- Product Image
Sale

Angioplasty Balloons Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5665821
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Angioplasty Balloons Market is projected to reach USD 2.77 Billion in 2026. It is expected to continue growing at a CAGR of 5.24%, reaching USD 3.78 Billion by 2032.

Angioplasty balloons are central to percutaneous transluminal coronary angioplasty and peripheral vascular intervention, enabling clinicians to dilate narrowed or obstructed vessels, optimize lesion preparation, and restore blood flow in patients with coronary artery disease, peripheral artery disease, and other vascular stenoses. Demand is supported by the well-documented global cardiovascular disease burden, rising diabetes and obesity prevalence, population aging, and increased use of minimally invasive endovascular procedures. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, while diabetes and hypertension continue to elevate risks for coronary and peripheral arterial complications. Product innovation is focused on drug-coated balloons, scoring and cutting balloons, high-pressure non-compliant balloons, specialty balloons for complex calcified lesions, and improved catheter deliverability for tortuous anatomy. The angioplasty balloon landscape is shaped by clinical evidence, reimbursement policies, regulatory scrutiny, hospital procurement standards, and physician preference for devices that improve procedural success while reducing restenosis, vessel trauma, and repeat intervention.

Transformative Shifts in the Angioplasty Balloon Landscape

The angioplasty balloon landscape is being reshaped by a shift from conventional vessel dilation toward lesion-specific and outcome-focused therapy. Drug-coated balloons have gained clinical relevance in selected coronary and peripheral indications because they deliver antiproliferative therapy without leaving a permanent implant, supporting treatment strategies where avoiding additional metal layers is preferred. At the same time, specialty balloons such as scoring, cutting, and ultra-high-pressure balloons are increasingly used for resistant, fibrotic, or calcified lesions that require controlled plaque modification before stenting or as part of a stent-free approach. Healthcare systems are prioritizing shorter procedure times, reduced hospitalization, fewer complications, and lower repeat revascularization rates, encouraging adoption of angioplasty balloon devices supported by robust clinical and real-world evidence. Regulatory expectations are rising around drug-device combination safety, biocompatibility, coating integrity, particulate release, sterilization validation, and long-term outcomes, while hospitals are strengthening value-based purchasing requirements that link device selection to safety, efficiency, and documented clinical performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative impact across the angioplasty balloon ecosystem by improving diagnosis, procedural planning, device selection, workflow efficiency, and post-procedure surveillance. AI-enabled imaging analytics can support assessment of lesion length, vessel diameter, plaque morphology, calcium burden, and anatomical complexity using angiography, intravascular ultrasound, optical coherence tomography, computed tomography angiography, and electronic health record data. These capabilities can help physicians select balloon type, diameter, length, inflation strategy, and adjunctive therapy more consistently, particularly in complex coronary and peripheral interventions. In manufacturing and quality systems, AI can enhance process monitoring, defect detection, coating uniformity assessment, and predictive maintenance, supporting compliance with stringent medical device standards. In clinical operations, machine learning can improve patient risk stratification, identify restenosis risk patterns, and support registry-based evidence generation. However, adoption depends on validated algorithms, transparent clinical decision support, cybersecurity controls, interoperability with hospital systems, bias mitigation, and regulatory pathways that ensure AI tools are safe, explainable, and clinically meaningful.

Key Regional Insights

In Asia-Pacific, angioplasty balloon adoption is supported by high cardiovascular disease burden, expanding interventional cardiology capacity, rapid hospital infrastructure development, and growing access to catheterization laboratories in large urban centers, with China, India, Japan, South Korea, and Australia serving as major demand centers. North America demonstrates mature procedural adoption, advanced reimbursement frameworks, established use of complex endovascular techniques, and strong clinical guideline adherence, with device selection often shaped by evidence generation, hospital value analysis, and post-market safety surveillance. Europe benefits from structured regulatory oversight, strong clinical research networks, and widespread adoption of minimally invasive cardiovascular care, while procurement is influenced by health technology assessment, cost containment, and clinical outcome documentation. Latin America is characterized by rising need for cardiovascular and peripheral vascular interventions, uneven access between public and private healthcare systems, and increasing investment in specialist training and vascular centers, particularly in Brazil and Mexico. Africa faces higher access constraints due to limited catheterization infrastructure, workforce shortages, and affordability challenges, although urban referral hospitals and public-private investments are gradually improving availability of advanced cardiovascular interventions. The Middle East is expanding interventional capacity through tertiary care investment, medical tourism initiatives, and specialty cardiac centers, particularly across high-income Gulf healthcare systems where diabetes, obesity, and hypertension are prominent public health priorities.

Key Group Insights

NATO member countries overlap with several advanced cardiovascular markets and emphasize resilient medical supply chains, device safety, and healthcare system readiness, factors that have become more prominent amid geopolitical disruptions and medical technology supply chain risk management. G7 countries represent mature, high-standard healthcare systems where angioplasty balloon utilization is guided by clinical evidence, physician expertise, regulatory oversight, post-market surveillance, and value-based procurement. BRICS countries combine large patient populations with expanding procedure volumes and domestic healthcare modernization, but market access is shaped by price sensitivity, local manufacturing policies, reimbursement variation, and regional disparities in specialist care. The European Union presents a highly regulated and evidence-driven environment, where medical device regulation, post-market clinical follow-up, health technology assessment, and public procurement policies shape angioplasty balloon adoption. ASEAN demand for angioplasty balloons is influenced by expanding healthcare access, rising diabetes and hypertension prevalence, and increasing investment in cardiac catheterization services across major economies, although reimbursement diversity and specialist availability remain important adoption factors. GCC countries are strengthening interventional cardiology and vascular care through well-funded hospital systems, national health transformation programs, and high use of advanced medical technologies, supported by the region’s significant cardiometabolic disease burden.

Key Country Insights

China is rapidly expanding advanced cardiovascular and peripheral vascular intervention capacity, supported by hospital modernization, domestic device development, centralized procurement reforms, and high patient volume linked to coronary artery disease, diabetes, and aging demographics. The United States remains a major center for angioplasty balloon use due to high cardiovascular disease prevalence, extensive catheterization laboratory networks, advanced reimbursement mechanisms, and strong adoption of coronary and peripheral interventions. Japan demonstrates high clinical sophistication, aging population dynamics, and strong adoption of precision endovascular techniques, while India is driven by rising coronary artery disease, diabetes, and urban hospital expansion, with price sensitivity and access outside major cities remaining central issues. Germany is a leading European hub for interventional cardiology, supported by high procedural capacity, specialist expertise, and broad hospital infrastructure, while the United Kingdom emphasizes evidence-based device selection through national clinical guidance, centralized procurement influences, and strong focus on outcomes and cost-effectiveness. Australia benefits from advanced specialist care, high-quality registries, and structured reimbursement, while France maintains advanced cardiovascular care delivery with strong regulatory and reimbursement oversight. South Korea combines advanced hospital infrastructure, strong clinical expertise, and rapid adoption of minimally invasive cardiovascular technologies, while Italy and Spain combine mature interventional practices with public health system budget discipline and regional procurement variation. Canada shows steady procedural demand supported by universal healthcare coverage, regionalized cardiac care systems, and evidence-based technology assessment, although access can vary by province and procedural capacity. Russia presents demand linked to cardiovascular disease burden and large geography, with access influenced by regional healthcare infrastructure and supply chain conditions. Brazil has one of Latin America’s largest cardiovascular intervention bases, supported by major urban cardiac centers and a growing burden of diabetes, hypertension, and peripheral artery disease, while Mexico is expanding interventional cardiology access through private-sector growth and public hospital modernization, with affordability and reimbursement remaining key considerations.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed innovation that addresses complex lesions, restenosis prevention, deliverability, procedural efficiency, and long-term patient outcomes. Development strategies should include robust clinical study design, real-world evidence programs, and post-market surveillance for drug-coated balloons, specialty balloons, and next-generation catheter platforms. Manufacturers should strengthen coating consistency, balloon compliance control, crossing profile optimization, trackability, and burst-pressure reliability while aligning quality systems with global regulatory requirements. Commercial teams should tailor market access strategies to local reimbursement, hospital procurement, and physician training needs, especially in regions with expanding interventional infrastructure. Partnerships with hospitals, academic investigators, and digital health developers can support procedural education, AI-enabled imaging integration, and registry-based outcome tracking. Supply chain resilience should be improved through diversified sourcing, validated manufacturing redundancy, and proactive risk monitoring for polymers, coatings, guidewire-compatible components, contrast-compatible materials, and sterilization capacity. Leaders should also invest in physician education for lesion-specific balloon selection, sizing, inflation protocols, and safe use practices, particularly for drug-coated, scoring, cutting, and high-pressure angioplasty balloon technologies.

Research Methodology

This executive summary is developed through a structured secondary research approach using verified public-domain and industry-relevant sources, including regulatory guidance, clinical practice guidelines, peer-reviewed medical literature, disease burden publications, hospital procurement trends, health technology assessment references, and medical device safety communications. The methodology emphasizes triangulation of clinical, regulatory, procedural, and macro-healthcare indicators to identify evidence-based patterns affecting angioplasty balloon adoption. Regional, group, and country insights are assessed through healthcare infrastructure maturity, cardiovascular disease prevalence, reimbursement environment, catheterization laboratory access, specialist availability, regulatory requirements, and documented trends in minimally invasive vascular intervention. The analysis excludes market sizing, market share, revenue estimation, and forecasting, focusing instead on qualitative and data-backed drivers, barriers, innovation trends, and strategic implications.

Conclusion

Angioplasty balloons remain essential technologies in modern coronary and peripheral vascular intervention, with continued relevance driven by cardiovascular disease burden, minimally invasive treatment adoption, and demand for improved lesion-specific outcomes. The clinical landscape is moving toward drug-coated, specialty, and high-performance balloon platforms supported by stronger evidence, regulatory compliance, and real-world outcome tracking. Artificial intelligence, advanced imaging, and digital clinical workflows are strengthening procedural planning and post-procedure monitoring, while regional adoption continues to depend on reimbursement, infrastructure, clinician expertise, affordability, and supply continuity. Industry participants that combine clinically validated innovation, resilient supply chains, physician education, and region-specific access strategies will be better positioned to support safer, more effective, and more widely available angioplasty balloon interventions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Angioplasty Balloons Market, by Product Type
7.1. Introduction
7.2. Coronary Angioplasty Balloons
7.2.1. Standard (Semi-Compliant) Balloons
7.2.2. Non-Compliant Balloons
7.2.3. Cutting and Scoring Balloons
7.3. Peripheral Angioplasty Balloons
7.3.1. Drug-Coated Peripheral Balloons
7.3.2. High-Pressure Peripheral Balloons
7.3.3. Specialty Peripheral Balloons
7.4. Neurovascular Balloons
7.4.1. Remodeling Balloons
7.4.2. Occlusion Balloons
8. Angioplasty Balloons Market, by Material Type
8.1. Introduction
8.2. Nylon Balloons
8.3. Polyurethane Balloons
8.4. Polyethylene Terephthalate Balloons
8.5. Pebax Balloons
9. Angioplasty Balloons Market, by Balloon Diameter
9.1. Introduction
9.2. Small
9.3. Medium
9.4. Large
10. Angioplasty Balloons Market, by Sales Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributor and Dealer Sales
10.3.1. Large-Scale Distributor Networks
10.3.2. Independent Dealer Networks
10.4. Online and E-Procurement
11. Angioplasty Balloons Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Centers
11.4. Hospitals
11.5. Specialty Clinics
12. Angioplasty Balloons Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Angioplasty Balloons Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Angioplasty Balloons Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Acrostak Int. Distr. Sarl
16.3. AngioDynamics, Inc.
16.4. Asahi Intecc Co., Ltd.
16.5. B. Braun SE
16.6. Balton Sp. z o.o.
16.7. Becton, Dickinson and Company
16.8. BIOTRONIK SE & Co. KG
16.9. Boston Scientific Corporation
16.10. BrosMed Medical Co., Ltd.
16.11. Cardinal Health, Inc.
16.12. Concept Medical Inc.
16.13. Cook Group Incorporated
16.14. Cordis
16.15. ENDOCOR GmbH
16.16. Hexacath
16.17. InSitu Technologies Inc.
16.18. iVascular S.L.U.
16.19. Kaneka Corporation
16.20. Koninklijke Philips N.V
16.21. Lepu Medical Technology(Beijing)Co., Ltd.
16.22. Medtronic PLC
16.23. Merit Medical Systems, Inc.
16.24. MicroPort Scientific Corporation
16.25. Nipro Medical Corporation
16.26. phenox GmbH
16.27. Scitech Medical
16.28. Teleflex Incorporated.
16.29. Terumo Medical Corporation
List of Figures
FIGURE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANGIOPLASTY BALLOONS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CORONARY ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CORONARY ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CORONARY ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL STANDARD (SEMI-COMPLIANT) BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL STANDARD (SEMI-COMPLIANT) BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL STANDARD (SEMI-COMPLIANT) BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NON-COMPLIANT BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NON-COMPLIANT BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NON-COMPLIANT BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CUTTING AND SCORING BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CUTTING AND SCORING BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CUTTING AND SCORING BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PERIPHERAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG-COATED PERIPHERAL BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG-COATED PERIPHERAL BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG-COATED PERIPHERAL BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HIGH-PRESSURE PERIPHERAL BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HIGH-PRESSURE PERIPHERAL BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HIGH-PRESSURE PERIPHERAL BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SPECIALTY PERIPHERAL BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SPECIALTY PERIPHERAL BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SPECIALTY PERIPHERAL BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEUROVASCULAR BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEUROVASCULAR BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEUROVASCULAR BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL REMODELING BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL REMODELING BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL REMODELING BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL OCCLUSION BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL OCCLUSION BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OCCLUSION BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NYLON BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NYLON BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NYLON BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL POLYURETHANE BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL POLYURETHANE BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL POLYURETHANE BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL POLYETHYLENE TEREPHTHALATE BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL POLYETHYLENE TEREPHTHALATE BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL POLYETHYLENE TEREPHTHALATE BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PEBAX BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PEBAX BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PEBAX BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SMALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SMALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SMALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MEDIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MEDIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MEDIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL LARGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL LARGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL LARGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DISTRIBUTOR AND DEALER SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DISTRIBUTOR AND DEALER SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DISTRIBUTOR AND DEALER SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL LARGE-SCALE DISTRIBUTOR NETWORKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL LARGE-SCALE DISTRIBUTOR NETWORKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL LARGE-SCALE DISTRIBUTOR NETWORKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INDEPENDENT DEALER NETWORKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INDEPENDENT DEALER NETWORKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL INDEPENDENT DEALER NETWORKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ONLINE AND E-PROCUREMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ONLINE AND E-PROCUREMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ONLINE AND E-PROCUREMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 103. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 104. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 109. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 133. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 134. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 135. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 136. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 137. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 139. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 154. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 155. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 156. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 157. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 158. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 160. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 164. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 165. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 166. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 167. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 168. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 170. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 174. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 175. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 176. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 177. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 178. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 180. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 194. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 195. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 196. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 198. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 200. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 204. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 205. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 206. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 207. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 208. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 210. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 213. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 215. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 216. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 217. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 218. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 219. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 221. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 235. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 236. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 237. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 238. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 239. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 241. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 245. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 246. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 247. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 248. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 249. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 251. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 255. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 256. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 257. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 258. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 259. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 261. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 273. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 274. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 275. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 276. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 277. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 278. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 279. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 280. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 281. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 283. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 284. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 285. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 286. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 287. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 288. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 289. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 290. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 291. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 294. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 295. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 296. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 297. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 298. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 299. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 301. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 303. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 304. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 305. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 306. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 307. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 308. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 309. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 310. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 311. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 312. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 313. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 314. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 315. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 316. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 317. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 318. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 319. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 320. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 321. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 322. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 323. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 324. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 325. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 326. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 327. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 328. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 329. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 330. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DISTRIBUTOR AND DEALER SALES, 2018-2032 (USD MILLION)
TABLE 331. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 332. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 333. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 334. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 335. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2018-2032 (USD MILLION)
TABLE 336. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY NEUROVASCULAR BALLOONS, 2018-2032 (USD MILLION)
TABLE 337. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 338. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY BALLOON DIAMETER, 2018-2032 (USD MILLION)
TABLE 339. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 340. BRAZIL ANGIOPLASTY BALLOONS

Companies Mentioned

  • Abbott Laboratories
  • Acrostak Int. Distr. Sarl
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun SE
  • Balton Sp. z o.o.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Cardinal Health, Inc.
  • Concept Medical Inc.
  • Cook Group Incorporated
  • Cordis
  • ENDOCOR GmbH
  • Hexacath
  • InSitu Technologies Inc.
  • iVascular S.L.U.
  • Kaneka Corporation
  • Koninklijke Philips N.V
  • Lepu Medical Technology(Beijing)Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • phenox GmbH
  • Scitech Medical
  • Teleflex Incorporated.
  • Terumo Medical Corporation

Table Information

Report AttributeDetails
No. of Pages194
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.77 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.78 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Angioplasty Balloons - Global Strategic Business Report - Product Image

Angioplasty Balloons - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Angioplasty Balloons Market Size, Share, Trends and Forecast by Product Type, Application, Material, End User, and Region, 2026-2034 - Product Image

Angioplasty Balloons Market Size, Share, Trends and Forecast by Product Type, Application, Material, End User, and Region, 2026-2034

  • Report
  • 147 Pages
  • Global
From
Angioplasty Balloons Market - Product Image

Angioplasty Balloons Market

  • Report
  • 150 Pages
  • Global
From
Angioplasty Balloons: Market Share, and Growth Analysis by Product Type (Non-Compliant Balloons, Compliant Balloons, Drug-Eluting Balloons), Application, End User, Technology - Product Image

Angioplasty Balloons: Market Share, and Growth Analysis by Product Type (Non-Compliant Balloons, Compliant Balloons, Drug-Eluting Balloons), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Angioplasty Balloons Market Report 2026 - Product Image

Angioplasty Balloons Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Angioplasty Balloon Market

The Angioplasty Balloon market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to open blocked or narrowed arteries and veins. Angioplasty balloons are typically inserted into the body through a catheter and inflated to widen the vessel. The procedure is often used to treat coronary artery disease, peripheral artery disease, and other conditions. The Angioplasty Balloon market is highly competitive, with a variety of manufacturers offering a range of products. Companies in the market include Boston Scientific, Medtronic, Abbott, B. Braun, and Terumo. These companies offer a range of products, including balloons, catheters, and other accessories. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.